Objective-To compare high fibre diet, basal insulin supplements and a regimen of insulin four times daily in non-insulin dependent (type II) diabetic patients who were poorly controlled with sulphonylureas.
Setting-Teaching hospital diabetic clinics. Patients-33 patients who had had diabetes for at least two years and had haemoglobin A1 concentrations over 10% despite receiving nearly maximum doses of oral hypoglycaemic agents. No absolute indications for treatment with insulin.
Interventions-During the high fibre diet daily fibre intake was increased by a mean of 16 g (95% confidence interval 12 to 20 g.) Twenty five patients were then started on once daily insulin. After three months 14 patients were started on four injections of insulin daily.
Endpoint-Control of diabetes (haemoglobin A1 concentration <10% and fasting plasma glucose concentration <6 mmol/l) or completion of six months on insulin treatment.
Measurements and main results-No change in weight, diet, or concentrations of fasting glucose or haemoglobin A1 occurred during run in period. During high fibre diet there were no changes in haemoglobin A1 concentrations, but mean fasting glucose concentrations rose by 1*7 mmol/l (95% confidence interval 0*9 to 2 5, p<0 01). With once daily insulin mean concentrations of fasting plasma glucose fell from 12*6 to 7*6 mmol/l (p<0001) and haemoglobin A1 from 14-6% to 11-2% (p<0 001). With insulin four times daily concentrations of haemoglobin A1 fell from 11*5% to 9*6% (p<002). Lipid concentrations were unchanged by high fibre diet. In patients receiving insulin the mean cholesterol concentrations fell from 7*1 to 6-4 mmol/l (p<00001), high density lipoprotein concentrations rose from 1.1 to 1-29 mmol/l (p<001), and triglyceride concentrations fell from 2*67 to 1*86 mmol/ I (p<O0O5). Patients taking insulin gained weight and those taking it four times daily gained an average of 4.2kg.
Introduction
Many patients with type II diabetes are poorly controlled when taking maximum doses of sulphonylureas with or without metformin.'-3 Such patients are usually recommended to change to insulin, although we have shown in the only prospective randomised study to date that this does not guarantee better control.4 This earlier study was criticised because the regimen ofinsulin once daily was not ideal and the diet, which provided 40% of energy from carbohydrate with no added fibre, was out of line with the new recommendations of national diabetes associations.56 Mann et al suggested that many of our patients could have been "rescued" by a high fibre diet,' and we now report a sequential comparison of a high fibre diet, basal insulin supplements, and a regimen of insulin four times daily in type II diabetic patients who were poorly controlled with sulphonylureas.
Patients, study design, and methods
PATIENTS
We chose patients who had had diabetes for at least two years and had haemoglobin Al concentrations over 10% even though they were receiving oral hypoglycaemic agents in near maximum doses; they had poor glycaemic control when taking tablets but did not have absolute indications for insulin (symptoms, islet cell antibodies, ketonuria, progressive weight loss, or progressive increase in haemoglobin Al concentration). Those whose haemoglobin Al had varied by more than 2% or who had lost more than 2 kg over the previous six months were excluded.
STUDY DESIGN
The study was divided into three parts: a run in period lasting two to three months, a high fibre diet maintained for six months, and insulin given subsequently for six months.
During the run in period self monitoring of blood glucose concentrations with reagent strips (BM 1-44; Boehringer Mannheim) was taught. It was carried out throughout the study. Seven point profiles ( at -20°C. The intra-assay and interassay coefficients of variation were 1-7% and 2 5% for cholesterol, 1-3% and 2 1% for triglycerides, and 2 -5% and 4 -5% for high density lipoprotein cholesterol, respectively. Food intakes were assessed from records kept for five days (three weekdays and a weekend) at the beginning and end of the run in period, after six months on the high fibre diet, and after six months' treatment with insulin. A computer programme (Microdiet, University of Salford) was used for nutritional analysis.
Results were analysed with Student's paired t test, Wilcoxon's signed rank test, and Pearson's correlation coefficient, as appropriate; 95% confidence intervals of the differences between means were calculated, and a p value of <0 05 was regarded as significant.
Results
Thirty eight patients were recruited, of whom five withdrew in the first three months. concentration (r=0 03), whether or not patients whose fibre intake rose by < 10 g/day were excluded. Fasting plasma glucose concentration deteriorated significantly, from 10-8 mmol/l at the end of the run in period to 12-6 mmol/l at the end of the period on a high fibre diet (mean increase 1-7 mmol/l (95% confidence interval 09 to 2 5, p<001). Fasting plasma glucose concentration rose only in patients whose intake of fibre increased by >10 g/day (mean increase 2 1 mmol/l (95% confidence interval 0-6 to 3.6, p<001), and was unchanged in those whose intake increased by <10 g/day (mean change 0 7 mmol/l (95% confidence interval -0 5 to 1-9). An increased intake of fibre was accompanied by a mean increase in energy intake of 1 35 MJ/day (95% confidence interval 0-51 to 2 19, p<001) (figure 2). Daily carbohydrate intake Mean change in fibre intake (g/day)
FIG 2-Mean changes in daily intake of energy related to mean changes in daily intake offibre in 28 diabetic patients taking a high fibre diet increased from 174 g to 229 g (mean increase 55 g, 95% confidence interval 30 to 80, p<0*0001) during the period on a high fibre diet and remained at the higher level during insulin treatment (table II) . Carbohydrate intake averaged 35% of total energy intake during the run in period, rising to 40% during the high fibre period (mean increase 4%, 95% confidence interval 2 to 6, p<0-001). Fat intake during the run in period was 45% of total energy intake, decreasing to 41% on the high fibre diet (mean difference -3-6%, 95% confidence interval -1 9 to-53, p<0*0001).
INSULIN TREATMENT
After six months on a high fibre diet only two patients had achieved the target concentrations of blood glucose; three others refused insulin. Of the 28 who started taking insulin zinc suspension once daily, three dropped out because of dislike of injections or intervening illness. The remaining 25 injected insulin zinc suspension in the evening, which led to noticeable improvement in fasting plasma glucose concentrations (from 12-6 to 7 6 mmol/l, mean difference -5 0 mmol, 95% confidence interval -4-6 to -5 4, p<0-0001) and haemoglobin Al (from 14-6% to 11-2%, mean difference -3 4%, 95% confidence interval -3 0 to -3 8, p<0 001). The mean total daily dose of insulin was 36 units (range 29 to 43); in 16 patients with late afternoon hyperglycaemia the dose was split. Only seven ofthe 25 patients reached the target concentration of haemoglobin Al of s, 10% after six months of treatment with insulin. At this stage three asked to go back to tablets (one disliked injections and two had recurrent severe nocturnal hypoglycaemia).
Fourteen of the remaining 22 patients were offered the injection device and completed a mean of 3-4 months on four injections a day (range 2-5 months).
These patients had a further fall in haemoglobin Al concentrations, from 11 5% to 9-6% (mean difference -1-8%, 95% confidence interval -1-4 to -2-2, p<002), but at the expense of more weight gain. After six months of insulin treatment they had increased their weight by a mean of 4-2 kg (95% confidence interval 3 0 to 5 4) compared with weight at the end of the six months of the high fibre diet.
C PEPTIDE AND LIPIDS
Mean fasting concentration ofC peptide at the end of the run in period was 0 75 nmol/l (range 0-24-1 6) and in all patients this increased after glucagon (mean increment 0 41 nmol/l (range 0 02-0 80). Neither the fasting concentration of C peptide nor the increment predicted change in control of blood glucose concentrations while patients were taking a high fibre diet.
Concentrations of fasting serum triglycerides, total cholesterol and high density lipoprotein cholesterol were unchanged by the high fibre diet. When the patients took insulin the mean concentration of total cholesterol fell from 7*1 to 6 4 mmolI (mean difference -0 6 mmolIl, 95% confidence interval -0-02 to -I 1, p<0O0001). Concentration of high density lipoprotein cholesterol rose from 1 10 to 1 29 nmol/l (mean difference 0-19 mmol/l, 95% confidence interval 0-08 to 0 30, p<001), and triglyceride concentrations fell from 2-67 to 1-86 mmol/l (mean difference -077 mmol/l, 95% confidence interval -0-08 to -1-46, p<0 05).
Discussion
National diabetes associations now recommend diets with a substantial amount of carbohydrate and fibre and little fat to improve glycaemic control and reduce the risk factors for ischaemic heart disease.56 '12 In our study such a diet in typical patients with type II diabetes taking maximum doses of tablets worsened glycaemic control: fasting plasma glucose concentration increased from 10-8 to 12-6 mmol/l and concentration of haemoglobin A1 increased from 13 1% to 14-6%. Our results are not particularly surprising as there is considerable doubt that simply increasing the amount of carbohydrate in the diet of diabetic patients will by itself improve metabolic control. Reaven and colleagues point out that most studies which have shown a beneficial effect of such diets on glycaemic control have been short term, using diets with an enormous and impracticable increase in intake of fibre for patients whose diabetes was already well controlled.'3 '4 For example, in a pioneering study an increase in fibre from 17 6 to 96 6 g/day produced a fall in fasting plasma glucose concentration from 6-7 to 5 7mmol/l.'"
We know of only three other studies in which a high carbohydrate, high fibre diet has been tried in patients with poorly controlled type II diabetes. In Oxford 15 patients with a mid-afternoon blood glucose concentration consistently over 12 mmol/l receiving high doses of sulphonylureas were recruited, and 11 completed the trial.'6 On their usual diet (fibre 26 g/day) fasting plasma glucose concentration was 9-6 mmol/l; after six weeks on a low carbohydrate diet (fibre 12 7 g/ day) it was 8-4 mmol/l; and after six weeks on a high carbohydrate diet (fibre 67-7 g/day) it was 6 8 mmol/l. In contrast, Coulston et al found their nine patients (mean fasting plasma glucose concentration of 10 8 mmol1) had a significant deterioration in glycaemic control after only 15 days on a 60% carbohydrate diet (fibre 38 g/day), whereas in patients with better control L a similar increase in carbohydrate led to a fall in fasting plasma glucose concentrations (from 5 9 to 5 3 mmol/l) I after four weeks. '7 In patients similar to those in our study increasing fibre from 11 g/4 18 MJ (1000 kcal) to g/4 18 MJ/day in a high carbohydrate diet had no effect on concentration of lipids or any measure of glycaemic control. '8 Even if intakes of fibre of 50-100 g/day had an effect in poorly controlled diabetes, it is doubtful whether ordinary people would eat this much fibre for more than a few weeks."' Our patients approved the variety BMJ VOLUME 297of foods on the list they had been given and liked the diet. Their most common sources of fibre were wholemeal bread, breakfast cereals, and baked beans or broad beans, but only two of the 33 patients managed to eat more than 50 g fibre a day. This finding is similar to those in other studies of outpatients, in which the limits of acceptability for long term diets seem to be taking 45% of total energy as carbohydrate and 25-35 g fibre a day.2"24 In a large prospective study in the United Kingdom in which patients were advised to take a prudent diet containing about 50% of energy as carbohydrate and as much fibre as is reasonable from generally available foods the energy intake and the related amount of fibre was a little lower than in our study (16-9 g fibre/4K18 MJ).24 It is difficult to prevent an increased energy intake on a high fibre, high carbohydrate diet without becoming a vegetarian. One study found that increasing fibre intake to 96 g/ day without increasing total energy intake meant taking 42% of total calories as legumes,'5 a change which our patients were not prepared to make. Our patients had a modest increase in energy intake (mean 1F35 MJ/day), but this did not lead to weight gain, presumably because it was offset by the deterioration in glycaemic control and loss of glucose in the urine.
The main aim of our study was to see whether increasing the intake of fibre from natural foods would benefit the typical outpatient with type II diabetes who has failed to achieve good control on large doses of sulphonylureas. It did not, and we think the present dietary recommendations for diabetics are unrealistic. When sulphonylureas fail standard advice is that the patient should be changed to insulin. Unfortunately, most evidence that good control is then achieved is anecdotal and from uncontrolled studies. 25 In a previous prospective randomised crossover study in 58 patients similar to those in this study we found that glycaemic control was improved in only 18 patients when they were given insulin. An additional 22 felt better, of whom only 10 showed better control. 4 The regimen of once daily Monotard MC in the morning was not ideal, and it has been suggested that a more logical treatment is to correct basal concentrations of plasma glucose with ultralente insulin.2627
In the present study we found that an evening dose of an average of 36 units of insulin zinc suspension led to noticeable improvement in concentrations of fasting plasma glucose and haemoglobin A1, although only a quarter of the patients reached the target haemoglobin Al concentration of 10%. The reason for these disappointing results may be that we used human ultralente insulin, which has an absorption rate (50% disappearance time) of only 15 hours compared with 44 hours for the bovine equivalent on which the regimen was originally based.28 Taking fast acting insulin before meals with a convenient delivery system (Novopen) was well accepted by our patients and led to further improvement (a fall in haemoglobin A1 concentration from 11 2% to 9 6%). Another benefit of insulin was the improvement in fasting concentrations of lipids, though mean serum concentrations of total cholesterol remained well above the optimum level of 5-2 mmol/l. 9
Reducing the concentrations of plasma lipids and improving the patient's glycaemic control are desirable goals for the doctor, but the patient may have more subjective aims. The main drawback of insulin treatment is weight gain, which in this study averaged 5 kg in the patients who took insulin four times daily. Unfortunately, maximum improvement in control will probably be achieved only by a multiple injection regimen; whether this is beneficial in the long term may be answered by the multicentre prospective study of diabetes being carried out in the United Kingdom.30
